Tag Archives: Novartis

Die Aktie von Sandoz begann den Börsenhandel bei 24 Franken, das ist deutlich tiefer, als von Analysten erwartet worden war. Das entspricht einem Börsenwert von elf Milliarden Franken.

Der Pharmakonzern Novartis hat seine Pläne für die Abspaltung der Generikasparte Sandoz konkretisiert: Anfang Oktober soll die Tochter als eigenständiges Unternehmen an die Börse kommen. Für fünf Novartis-Papiere gibt je eine Sandoz-Aktie als «Sachdividende».

Novartis erhöht seine Jahresprognosen und will bis zu 15 Milliarden Dollar in ein neues Aktienrückkaufprogramm investieren. Gleichzeitig präsentiert der Pharmakonzern ein paar Details zum Börsengang von Sandoz.

Der Pharmakonzern übernimmt das amerikanische Biotech-Unternehmen Chinook für 3,5 Milliarden Dollar. Die Aktionäre sollen 3,2 Milliarden Dollar in bar oder 40 Dollar je Aktie erhalten.

Der Basler Pharmakonzern Novartis hat Gilbert Ghostine zum Präsidenten für seine Generika-Tochter Sandoz bestimmt. Diese soll bekanntlich noch in diesem Jahr vom Konzern abgespalten und separat an die Börse gebracht werden.

The Novartis offices in Basel, Switzerland. Keystone / Georgios Kefalas Swiss pharma company Novartis will pay $729 million (CHF688 million) to US authorities in an out-of-court settlement over various charges, including that the company bribed doctors to use its drugs. Audrey Strauss, the acting Manhattan US Attorney, said the firm had paid out for “speaking fees, exorbitant meals, and top-shelf alcohol that were nothing more than bribes to get doctors across the...

Novartis has aborted its latest patent filing at the European Patent Office. (Keystone / Georgios Kefalas) Swiss pharmaceutical giant Novartis has backed down in a patent dispute over the leukaemia therapy Kymriah following opposition from NGOs. The Swiss NGO Public Eye is claiming victory in the European Patent Officeexternal link battle, but Novartis says the patent in question was only one of several it has in place on the (CAR)-T cell therapy treatment it had...

Switzerland is the only country among the 47 members of the Council of Europe which does not have a law governing political party financing. (© Keystone / Gaetan Bally) Switzerland’s biggest firms – mainly banks, pharmaceutical firms and insurance companies – donate at least CHF5 million ($5 million) a year to political parties and candidates, a survey has revealed. The poll of 140 companies by Swiss public radio RTS, published on Tuesdayexternal link, found that one...

Novartis imports some 120 million packs of medicines into the UK each year. - Click to enlarge Swiss pharmaceuticals giant Novartis says a no-deal Brexit could hurt patients and that it is stockpiling medicines in the UK to help ensure continuity of supply. In a press releaseexternal link on Friday, it said that after the British parliament’s rejection of Prime Minister Theresa May’s Brexit deal, “the risk of UK...

Novartis currently employs 13,000 people across Switzerland The pharmaceutical giant Novartis will cut about 2,200 jobs in Switzerland over the next four years. Nearly 1,500 jobs are affected in production and about 700 in services. This restructuring is part of the manufacturing strategy launched in 2015 to adapt the industrial base to a reduced product portfolio, announced Novartis on Tuesdayexternal link. It...